AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE

AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE was reported 50 times

AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LIP NEOPLASM BENIGN 1 0.0667
1 OXYGEN CONSUMPTION 1 0.0062
2 SUBGALEAL HAEMATOMA 1 0.0060
3 POSTERIOR CAPSULE OPACIFICATION 1 0.0029
4 APPENDICOLITH 1 0.0026
5 HYPERFERRITINAEMIA 1 0.0023
6 ALLERGY TO METALS 1 0.0016
7 METAPNEUMOVIRUS INFECTION 1 0.0013
8 PRODUCT CONFUSION 1 0.0013
9 HYPERSENSITIVITY PNEUMONITIS 1 0.0009
10 CHOLANGIOCARCINOMA 1 0.0007
11 PNEUMONIA CYTOMEGALOVIRAL 1 0.0005
12 HYPERPHOSPHATAEMIA 1 0.0005
13 IDIOPATHIC INTRACRANIAL HYPERTENSION 1 0.0004
14 AORTIC ARTERIOSCLEROSIS 1 0.0004
15 BLOOD PHOSPHORUS INCREASED 1 0.0004
16 LUNG CONSOLIDATION 1 0.0004
17 EOSINOPHILIC PNEUMONIA 1 0.0003
18 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3 0.0003
19 BACTERIAL SEPSIS 1 0.0003
20 HYPOPHOSPHATAEMIA 2 0.0003
21 THYROID MASS 1 0.0003
22 EPIGASTRIC DISCOMFORT 1 0.0003
23 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
24 PRODUCT DISPENSING ISSUE 1 0.0002
25 METASTATIC NEOPLASM 1 0.0002
26 IRON DEFICIENCY 1 0.0002
27 MUCOUS STOOLS 1 0.0002
28 COLORECTAL CANCER STAGE III 1 0.0002
29 BLOOD URIC ACID INCREASED 1 0.0002
30 PHOTOPSIA 1 0.0002
31 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
32 WRONG PRODUCT ADMINISTERED 1 0.0001
33 MYASTHENIA GRAVIS 1 0.0001
34 SPINAL COMPRESSION FRACTURE 1 0.0001
35 INFUSION SITE ERYTHEMA 1 0.0001
36 PYELONEPHRITIS 1 0.0001
37 LUNG INFILTRATION 1 0.0001
38 BRAIN NEOPLASM 1 0.0001
39 BACTERIAL INFECTION 2 0.0001
40 APPENDICITIS 1 0.0001
41 DIZZINESS POSTURAL 1 0.0001
42 CHOKING 2 0.0001
43 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
44 TEMPERATURE INTOLERANCE 1 0.0001
45 RENAL PAIN 1 0.0001
46 VENTRICULAR FIBRILLATION 1 0.0001
47 THYROID CANCER 1 0.0001
48 HYPERCALCAEMIA 1 0.0001
49 PHARYNGITIS 1 0.0001
50 HIATUS HERNIA 1 0.0001
51 HYPOMAGNESAEMIA 1 0.0001
52 CARDIOGENIC SHOCK 1 0.0001
53 INSURANCE ISSUE 1 0.0001
54 BASAL CELL CARCINOMA 1 0.0001
55 ABSCESS 1 0.0001
56 VIRAL INFECTION 2 0.0001
57 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
58 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
59 FOOT FRACTURE 1 0.0001
60 BLOOD URINE PRESENT 1 0.0001
61 LOWER LIMB FRACTURE 1 0.0001
62 KIDNEY INFECTION 1 0.0001
63 BONE MARROW FAILURE 1 0.0000
64 RETCHING 1 0.0000
65 SKIN CANCER 1 0.0000
66 PANCREATITIS ACUTE 1 0.0000
67 PRODUCT AVAILABILITY ISSUE 1 0.0000
68 COLORECTAL CANCER 2 0.0000
69 BLOOD PRESSURE FLUCTUATION 1 0.0000
70 HEPATIC CANCER 1 0.0000
71 NEURALGIA 1 0.0000
72 DRUG RESISTANCE 1 0.0000
73 ANAPHYLACTIC SHOCK 1 0.0000
74 RASH GENERALISED 1 0.0000
75 DEAFNESS 1 0.0000
76 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
77 DIVERTICULITIS 1 0.0000
78 MENTAL STATUS CHANGES 1 0.0000
79 WOUND 1 0.0000
80 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
81 ASCITES 1 0.0000
82 OESOPHAGEAL CARCINOMA 1 0.0000
83 RESPIRATORY DISORDER 1 0.0000
84 NIGHT SWEATS 1 0.0000
85 HYPERKALAEMIA 1 0.0000
86 DYSPNOEA EXERTIONAL 1 0.0000
87 HOT FLUSH 2 0.0000
88 DISORIENTATION 1 0.0000
89 DRY MOUTH 2 0.0000
90 DYSKINESIA 1 0.0000
91 LUNG NEOPLASM MALIGNANT 1 0.0000
92 SEPTIC SHOCK 1 0.0000
93 INTENTIONAL PRODUCT MISUSE 2 0.0000
94 TINNITUS 1 0.0000
95 BLOOD CHOLESTEROL INCREASED 1 0.0000
96 PULMONARY EMBOLISM 2 0.0000
97 PRODUCTIVE COUGH 1 0.0000
98 INTERSTITIAL LUNG DISEASE 1 0.0000
99 DRY EYE 1 0.0000
100 ILLNESS 2 0.0000
101 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
102 DRUG INTERACTION 3 0.0000
103 HYPERTENSION 4 0.0000
104 RASH PRURITIC 1 0.0000
105 TREATMENT NONCOMPLIANCE 1 0.0000
106 ANAPHYLACTIC REACTION 1 0.0000
107 ARTHROPATHY 1 0.0000
108 HYPONATRAEMIA 1 0.0000
109 LETHARGY 1 0.0000
110 EYE IRRITATION 1 0.0000
111 PRODUCT SUBSTITUTION ISSUE 1 0.0000
112 STOMATITIS 1 0.0000
113 FEELING HOT 1 0.0000
114 ANAEMIA 3 0.0000
115 BLOOD CREATININE INCREASED 1 0.0000
116 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
117 BURNING SENSATION 1 0.0000
118 SLEEP DISORDER 1 0.0000
119 BRONCHITIS 1 0.0000
120 DYSGEUSIA 1 0.0000
121 HALLUCINATION 1 0.0000
122 CONDITION AGGRAVATED 4 0.0000
123 DIABETES MELLITUS 1 0.0000
124 ACUTE KIDNEY INJURY 2 0.0000
125 THROMBOSIS 1 0.0000
126 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
127 MUSCULOSKELETAL STIFFNESS 1 0.0000
128 BREAST CANCER 1 0.0000
129 SWELLING 1 0.0000
130 VOMITING 5 0.0000
131 DRUG INTOLERANCE 1 0.0000
132 SINUSITIS 1 0.0000
133 ABDOMINAL DISTENSION 1 0.0000
134 FALL 3 0.0000
135 SEPSIS 1 0.0000
136 THROMBOCYTOPENIA 1 0.0000
137 WEIGHT INCREASED 2 0.0000
138 PYREXIA 3 0.0000
139 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
140 DECREASED APPETITE 2 0.0000
141 CHILLS 1 0.0000
142 OEDEMA PERIPHERAL 1 0.0000
143 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
144 VISUAL IMPAIRMENT 1 0.0000
145 LOSS OF CONSCIOUSNESS 1 0.0000
146 HYPERHIDROSIS 1 0.0000
147 PSORIASIS 1 0.0000
148 DEHYDRATION 1 0.0000
149 PRODUCT QUALITY ISSUE 1 0.0000
150 NEUTROPENIA 1 0.0000
151 MEMORY IMPAIRMENT 1 0.0000
152 INFECTION 1 0.0000
153 PRODUCT DOSE OMISSION ISSUE 2 0.0000
154 BLOOD PRESSURE INCREASED 1 0.0000
155 CONFUSIONAL STATE 1 0.0000
156 URINARY TRACT INFECTION 1 0.0000
157 COVID-19 1 0.0000
158 PRODUCT USE ISSUE 1 0.0000
159 DYSPNOEA 3 0.0000
160 HYPOTENSION 1 0.0000
161 SOMNOLENCE 1 0.0000
162 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
163 ABDOMINAL PAIN UPPER 1 0.0000
164 ARTHRALGIA 2 0.0000
165 CONSTIPATION 1 0.0000
166 MALAISE 2 0.0000
167 ABDOMINAL PAIN 1 0.0000
168 DIZZINESS 2 0.0000
169 NAUSEA 3 0.0000
170 COUGH 1 0.0000
171 DIARRHOEA 2 0.0000
172 PNEUMONIA 1 0.0000
173 ASTHENIA 1 0.0000
174 FATIGUE 2 0.0000
175 RASH 1 0.0000
176 PAIN 1 0.0000
177 HEADACHE 1 0.0000
178 DEATH 1 0.0000
179 OFF LABEL USE 1 0.0000
180 DRUG INEFFECTIVE 1 0.0000